Suthahar, Navin
Meems, Laura M. G.
Withaar, Coenraad
Gorter, Thomas M.
Kieneker, Lyanne M.
Gansevoort, Ron T.
Bakker, Stephan J. L.
van Veldhuisen, Dirk J.
de Boer, Rudolf A.
Funding for this research was provided by:
Hartstichting (CVON SHE-PREDICTS-HF, grant 2017-21)
European Research Council (ERC CoG 818715, SECRETE-HF)
Article History
Received: 20 July 2021
Accepted: 10 November 2021
First Online: 7 January 2022
Competing interests
: The UMCG, which employs Dr. de Boer has received research grants and/or fees from AstraZeneca, Abbott, Boehringer Ingelheim, Cardior Pharmaceuticals GmbH, Ionis Pharmaceuticals Inc., Novo Nordisk and Roche. Dr. de Boer received speaker fees from Abbott, AstraZeneca, Bayer, Novartis, and Roche. The remaining authors have nothing to disclose.